Yiheng Capital Management, L.P.

Holdings History for Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value (VRDN)

Symbol: VRDN on Nasdaq
Investment type: Equity / Common Stock, $0.01 par value

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	2.8%	-4%	$6,495,833	208,735	-291,526	-58%	$31.12	Q4 2025
30 Sep 2025	3.6%	0%	$10,795,632	500,261	0		$21.58	Q3 2025
30 Jun 2025	2.5%	0%	$6,993,649	500,261	0		$13.98	Q2 2025
31 Mar 2025	2.4%	-1.2%	$6,743,518	500,261	-250,000		$13.48	Q1 2025
31 Dec 2024	3.2%	-0.41%	$14,382,503	750,261	-97,630	-12%	$19.17	Q4 2024
30 Sep 2024	3.6%	-0.42%	$19,289,520	847,891	-100,239	-11%	$22.75	Q3 2024
30 Jun 2024	1.7%	0%	$12,335,171	948,130	0		$13.01	Q2 2024
31 Mar 2024	2.4%	-0.71%	$16,601,756	948,130	-280,404	-23%	$17.51	Q1 2024
31 Dec 2023	3.3%	0%	$26,757,471	1,228,534	0		$21.78	Q4 2023
30 Sep 2023	1.7%	0%	$18,845,712	1,228,534	0		$15.34	Q3 2023
30 Jun 2023	2.5%	0%	$29,226,824	1,228,534	0		$23.79	Q2 2023
31 Mar 2023	2.4%	+0.53%	$31,253,905	1,228,534	+265,278	+28%	$25.44	Q1 2023
31 Dec 2022	2.2%	+1.3%	$28,136,708	963,256	+590,205	+158%	$29.21	Q4 2022
30 Sep 2022	0.72%	+0.72%	$7,651,000	373,051	+373,051	NEW	$20.51	Q3 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.